Toxicity of the alkylating agent bendamustin.
In acute toxicity studies the maximum tolerated dose (MTD), the LD50 and the LD100 of Bendamustin were determined in rats and mice after i.v. and oral administration. In a subchronic study male rats were given Bendamustin for 28 days at oral dose levels of 5, 10, 20 or 40 mg/kg/day. Chlorambucil was used as a standard at dose levels of 1, 5 and 10 mg/kg/day. Bodyweight gain, food and water intake, hematology, clinical chemistry and histopathology were evaluated. With quantitative differences the main target organs for both compounds were the bone marrow, the kidney, the intestine and the lymphatic system. Additionally, Chlorambucil caused a significant atrophy of the testes and a slight atrophy of the pancreas at a dose of 5 mg/kg/day. In conclusion, the data obtained may be used as a base to evaluate the therapeutic range of Bendamustin compared to Chlorambucil for the oral route.
D000477:Alkylating Agents / Q000633:toxicity; D000818:Animals; D001284:Atrophy; D000069461:Bendamustine Hydrochloride; D001835:Body Weight / Q000187:drug effects; D002699:Chlorambucil / Q000633:toxicity; D004064:Digestive System / Q000187:drug effects / Q000473:pathology; D007674:Kidney Diseases / Q000139:chemically induced; D007928:Lethal Dose 50; D008221:Lymphoid Tissue / Q000187:drug effects / Q000473:pathology; D008297:Male; D051379:Mice; D009503:Neutropenia / Q000139:chemically induced; D009588:Nitrogen Mustard Compounds / Q000633:toxicity*; D051381:Rats; D013737:Testis / Q000187:drug effects / Q000473:pathology
D000477:Alkylating Agents; D009588:Nitrogen Mustard Compounds; D002699:Chlorambucil; D000069461:Bendamustine Hydrochloride